Hepatic Resection clinical trials

Explore recruiting hepatic resection clinical trials.

Recruiting hepatic resection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatic Resection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Influence of Argipressin on blood loss during liver resection; a double-blinded, randomized, placebo-controlled trial (ARG-01)

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma Who Are at High Risk of Recurrence after Curative Hepatic Resection or Ablation (CheckMate 9DX: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9DX)

France, Austria, Germany, Netherlands, Spain, Romania +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients with Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (EMERALD-2)

Poland, Austria, Italy, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

PRODIGE 49 - OSCAR: Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 ± Irinotecan, and targeted therapy, in first-line treatment of metastatic colorectal cancer restricted to the liver

France, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hepatic Resection trials by city

Hepatic Resection in Toronto Hepatic Resection in Vancouver Hepatic Resection in Montreal Hepatic Resection in Calgary Hepatic Resection in Edmonton Hepatic Resection in Ottawa Hepatic Resection in Winnipeg Hepatic Resection in Quebec City Hepatic Resection in Hamilton Hepatic Resection in Kitchener Hepatic Resection in London Hepatic Resection in Halifax Hepatic Resection in New York Hepatic Resection in Los Angeles Hepatic Resection in Chicago Hepatic Resection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease